Springer Nature
13395_2019_198_MOESM5_ESM.tif (2.86 MB)

Additional file 5: of Preclinical rationale for entinostat in embryonal rhabdomyosarcoma

Download (2.86 MB)
posted on 2019-05-21, 05:00 authored by Narendra Bharathy, Noah Berlow, Eric Wang, Jinu Abraham, Teagan Settelmeyer, Jody Hooper, Matthew Svalina, Zia Bajwa, Martin Goros, Brian Hernandez, Johannes Wolff, Ranadip Pal, Angela Davies, Arya Ashok, Darnell Bushby, Maria Mancini, Christopher Noakes, Neal Goodwin, Peter Ordentlich, James Keck, Douglas Hawkins, Erin Rudzinski, Atiya Mansoor, Theodore Perkins, Christopher Vakoc, Joel Michalek, Charles Keller
Figure S5. Representative immunohistochemistry for CD68 of mouse eRMS tissue and primary cells. Necrotic tissue (a) showed few macrophages present, while viable tumor (b) showed a collection of many macrophages. Macrophage presence was observed as being the same for all treatment groups. (TIF 2929 kb)


National Institute of Health (US)